Company profile: Eikon Therapeutics
1.1 - Company Overview
Company description
- Provider of live-cell single-molecule tracking and super-resolution microscopy technologies for drug discovery, offering proprietary hardware, AI and machine learning integration, and custom reagents and automation to enable high-throughput analysis of protein dynamics and interactions, alongside a therapeutic pipeline in oncology, immunology, and neuroscience.
Products and services
- Therapeutic Pipeline: Clinical-stage and preclinical programs targeting serious diseases, with efforts in oncology, immunology, and neuroscience
- Single Molecule Tracking (SMT) Technology: Live-cell platform that visualizes individual protein motion to explore pharmaceutical activity with precision for drug discovery
- Super Resolution Microscopy: Nobel Prize–derived super-resolution system that measures protein dynamics in living cells to advance drug discovery
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Eikon Therapeutics
Quosa
HQ: United States
Website
- Description: Provider of software solutions for scientific literature management workflows, covering full-text articles, conference abstracts, and patents; offers integration with document delivery processes for seamless, automated access to full-text articles across organizations from subscriptions and open access.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quosa company profile →
GQ Life Sciences
HQ: United States
Website
- Description: Provider of life science information and search solutions: GenomeQuest, a patent search tool for DNA, RNA, and protein sequences with comprehensive comparison algorithms and a large indexed sequence database; and LifeQuest, a life science patent search platform using ontologies to understand biological queries and deliver complete, relevant results without false positives from non-life science patents.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GQ Life Sciences company profile →
Chemos
HQ: Germany
Website
- Description: Provider of ready-to-use solutions for laboratories and the chemical industry, offering raw materials for organic synthesis, active ingredients for the pharmaceutical and food industries, and various catalysts and crosslinkers; also provides manual filling lines for solid and liquid.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Chemos company profile →
ClinOne
HQ: United States
Website
- Description: Provider of clinical trial management solutions delivering web and mobile access to mission-critical trial details to improve enrollment, retention, site compliance, and patient experience. Offerings include Consent Management, Patient Engagement Portal, Site Hub, Sponsor & Monitor Hub (awareness, site selection, DEI data), Trial Awareness, and TeleVisit for remote video visits.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ClinOne company profile →
Strateos
HQ: United States
Website
- Description: Provider of SaaS-based robotic solutions for biology labs, offering the Strateos Cloud Lab for remote experiment design, execution, and analysis; lab automation software to manage instruments and workflows via the cloud; design and build services for modular smart labs; AI for drug discovery; discovery biology services; and automated small molecule drug discovery workflows.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Strateos company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Eikon Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Eikon Therapeutics
2.2 - Growth funds investing in similar companies to Eikon Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Eikon Therapeutics
4.2 - Public trading comparable groups for Eikon Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →